Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -56,624 | -65,578 | -15,577 | -83,795 | -35,465 |
| Depreciation Amortization | 2,016 | 8,971 | 6,860 | 4,724 | 2,445 |
| Accounts receivable | N/A | 9,387 | 8,137 | 8,136 | 6,783 |
| Accounts payable and accrued liabilities | -6,464 | 9,362 | 4,781 | 1,684 | 973 |
| Other Working Capital | -16,998 | 41,530 | 51,555 | -287 | -755 |
| Other Operating Activity | 11,625 | 3,016 | 2,795 | 347 | -3,477 |
| Operating Cash Flow | $-66,445 | $6,688 | $58,551 | $-69,191 | $-29,496 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,950 | -9,566 | -7,988 | -3,896 | -1,342 |
| Purchase Of Investment | -28,156 | -95,971 | -66,342 | -51,942 | -46,944 |
| Sale Of Investment | 44,078 | 169,625 | 125,982 | 82,378 | 27,548 |
| Other Investing Activity | 0 | 0 | -750 | -750 | 0 |
| Investing Cash Flow | $12,972 | $64,088 | $50,902 | $25,790 | $-20,738 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 27,606 | N/A | 0 | 0 | N/A |
| Debt Repayment | -1,907 | -948 | 0 | 0 | 0 |
| Common Stock Issued | 1,149 | 2,126 | 1,958 | 1,349 | 764 |
| Financing Cash Flow | $26,848 | $1,178 | $1,958 | $1,349 | $764 |
| Exchange Rate Effect | N/A | -1 | 0 | N/A | N/A |
| Beginning Cash Position | 188,002 | 116,049 | 116,049 | 116,049 | 116,049 |
| End Cash Position | 161,377 | 188,002 | 227,460 | 73,997 | 66,579 |
| Net Cash Flow | $-26,625 | $71,954 | $111,411 | $-42,052 | $-49,470 |
| Free Cash Flow | |||||
| Operating Cash Flow | -66,445 | 6,688 | 58,551 | -69,191 | -29,496 |
| Capital Expenditure | -2,950 | -9,566 | -7,988 | -3,896 | -1,342 |
| Free Cash Flow | -69,395 | -2,878 | 50,563 | -73,087 | -30,838 |